Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines
Conference object (Published version)
Metadata
Show full item recordAbstract
Introduction: Rhabdomyosarcoma (RMS) is the most common soft tissue
malignancy in children and adolescents. Respecting the age
of the patients and the tumor aggressiveness, investigation
of the molecular mechanisms of RMS tumorigenesis is
essential, most notably due to the possible identification of
novel therapeutic targets. To contribute to a better
understanding of the molecular pathology of RMS, we
investigated ANKRD1 (ankyrin repeat domain 1) gene,
considered a potential RMS diagnostic marker. The
changes in its expression are related to carcinogenesis and
resistance to chemotherapy in several types of tumors.
Keywords:
Rhabdomyosarcoma / ANKRD1 / Cajal bodies / Proteasomal degradationSource:
Molecular oncology, 2023, 17, 196-197Publisher:
- Wiley
Note:
- EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy
URI
https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13471https://imagine.imgge.bg.ac.rs/handle/123456789/1911
Institution/Community
Institut za molekularnu genetiku i genetičko inženjerstvoTY - CONF AU - Milošević, Emilija AU - Jasnić, Jovana AU - Novković, Mirjana AU - Cenni, V. AU - Bavelloni, A. AU - Kojić, Snežana PY - 2023 UR - https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13471 UR - https://imagine.imgge.bg.ac.rs/handle/123456789/1911 AB - Introduction: Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children and adolescents. Respecting the age of the patients and the tumor aggressiveness, investigation of the molecular mechanisms of RMS tumorigenesis is essential, most notably due to the possible identification of novel therapeutic targets. To contribute to a better understanding of the molecular pathology of RMS, we investigated ANKRD1 (ankyrin repeat domain 1) gene, considered a potential RMS diagnostic marker. The changes in its expression are related to carcinogenesis and resistance to chemotherapy in several types of tumors. PB - Wiley C3 - Molecular oncology T1 - Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines EP - 197 SP - 196 VL - 17 VL - Supplement 1 DO - doi.org/10.1002/1878-0261.13471 ER -
@conference{ author = "Milošević, Emilija and Jasnić, Jovana and Novković, Mirjana and Cenni, V. and Bavelloni, A. and Kojić, Snežana", year = "2023", abstract = "Introduction: Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children and adolescents. Respecting the age of the patients and the tumor aggressiveness, investigation of the molecular mechanisms of RMS tumorigenesis is essential, most notably due to the possible identification of novel therapeutic targets. To contribute to a better understanding of the molecular pathology of RMS, we investigated ANKRD1 (ankyrin repeat domain 1) gene, considered a potential RMS diagnostic marker. The changes in its expression are related to carcinogenesis and resistance to chemotherapy in several types of tumors.", publisher = "Wiley", journal = "Molecular oncology", title = "Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines", pages = "197-196", volume = "17, Supplement 1", doi = "doi.org/10.1002/1878-0261.13471" }
Milošević, E., Jasnić, J., Novković, M., Cenni, V., Bavelloni, A.,& Kojić, S.. (2023). Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines. in Molecular oncology Wiley., 17, 196-197. https://doi.org/doi.org/10.1002/1878-0261.13471
Milošević E, Jasnić J, Novković M, Cenni V, Bavelloni A, Kojić S. Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines. in Molecular oncology. 2023;17:196-197. doi:doi.org/10.1002/1878-0261.13471 .
Milošević, Emilija, Jasnić, Jovana, Novković, Mirjana, Cenni, V., Bavelloni, A., Kojić, Snežana, "Expression profiling of ANKRD1 in rhabdomyosarcoma cell lines" in Molecular oncology, 17 (2023):196-197, https://doi.org/doi.org/10.1002/1878-0261.13471 . .